SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-22-009977
Filing Date
2022-09-23
Accepted
2022-09-23 17:09:05
Documents
15
Period of Report
2022-09-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT pulse-8k_092022.htm   iXBRL 8-K 42952
2 LOAN AGREEMENT ex10-1.htm EX-10.1 165475
3 AMENDMENT TO EMPLOYMENT AGREEMENT ex10-2.htm EX-10.2 18233
4 PRESS RELEASE ex99-1.htm EX-99.1 15199
  Complete submission text file 0001387131-22-009977.txt   470427

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE plse-20220920.xsd EX-101.SCH 3203
6 XBRL LABEL FILE plse-20220920_lab.xml EX-101.LAB 34916
7 XBRL PRESENTATION FILE plse-20220920_pre.xml EX-101.PRE 22773
9 EXTRACTED XBRL INSTANCE DOCUMENT pulse-8k_092022_htm.xml XML 3646
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 221262966
SIC: 3841 Surgical & Medical Instruments & Apparatus